| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.05 | 0.8 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |